Analgesic effect of subcutaneous injection of different concentrations of methylene blue after hemorrhoidectomy: A retrospective study.

different concentrations hemorrhoidectomy methylene blue postoperative pain subcutaneous injection

Journal

Frontiers in surgery
ISSN: 2296-875X
Titre abrégé: Front Surg
Pays: Switzerland
ID NLM: 101645127

Informations de publication

Date de publication:
2023
Historique:
received: 27 12 2022
accepted: 20 03 2023
medline: 20 4 2023
pubmed: 20 4 2023
entrez: 20 04 2023
Statut: epublish

Résumé

Subcutaneous injection of methylene blue around the anus may help reduce postoperative pain. However, the concentration of methylene blue is still controversial. Therefore, Our study aims to investigate the efficacy and safety of different methylene blue injected concentrations subcutaneously in pain treatment after hemorrhoidectomy. A total of 180 consecutive patients with grade III or IV hemorrhoids from March 2020 to December 2021 were reviewed. All patients underwent hemorrhoidectomy under spinal anesthesia and were divided into three groups. Group A received subcutaneous injection of 0.1% methylene blue after hemorrhoidectomy, group B received subcutaneous injection of 0.2% methylene blue, and Group C did not received subcutaneous injection of methylene blue. The primary outcome measures were the visual analog scale (VAS) pain score on postoperative days 1, 2, 3, 7, 14, and total analgesic consumption within 14 days. Secondary outcomes were complications after hemorrhoidectomy, including acute urinary retention, secondary bleeding, perianal incision edema, and perianal skin infection, and the Wexner scores used to assess the level of anal incontinence at one and three months after surgery. There was no significant difference among three groups in sex, age, course of the disease, hemorrhoid grade and the number of incisions, and there was no significant difference in the volume of methylene blue injected between group A and group B. The VAS pain score and total analgesics consumption within 14 days in group A and group B were significantly lower than those in group C, but the differences between group A and group B were not statistically significant. The Wexner scores of group B were significantly higher than those of group A and group C one month after the operation, but the differences between group A and group C were not statistically significant. In addition, the Wexner score among three groups decreased to zero at three months after operation. There was no significant difference in the incidence of other complications among three groups. The perianal injection of 0.1% methylene blue and 0.2% methylene blue have a similar analgesic effect in pain treatment after hemorrhoidectomy, but 0.1% methylene blue has higher safety.

Identifiants

pubmed: 37077863
doi: 10.3389/fsurg.2023.1132277
pmc: PMC10106721
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1132277

Informations de copyright

© 2023 Long, Li and Li.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Pain Res Manag. 2022 Feb 04;2022:2033580
pubmed: 35154550
Br J Surg. 2015 Dec;102(13):1603-18
pubmed: 26420725
World J Surg. 2016 Jan;40(1):215-24
pubmed: 26578318
Colorectal Dis. 2020 Jun;22(6):650-662
pubmed: 32067353
Rev Recent Clin Trials. 2021;16(1):32-38
pubmed: 32250232
Dis Colon Rectum. 2018 Jul;61(7):824-829
pubmed: 29771804
Tech Coloproctol. 2019 Feb;23(2):143-149
pubmed: 30734161
Asian J Surg. 2018 Sep;41(5):431-437
pubmed: 28698000
Tech Coloproctol. 2020 Feb;24(2):145-164
pubmed: 31993837
Dis Colon Rectum. 2006 Nov;49(11):1741-8
pubmed: 16990976
Tech Coloproctol. 2012 Aug;16(4):295-9
pubmed: 22669483
Br J Surg. 2005 Dec;92(12):1481-7
pubmed: 16252313
Acta Chir Belg. 2019 Aug;119(4):224-230
pubmed: 30189793
World J Surg. 2017 Feb;41(2):603-614
pubmed: 27766395
Medicina (Kaunas). 2022 Mar 12;58(3):
pubmed: 35334594
Colorectal Dis. 2014 Aug;16(8):O283-7
pubmed: 24506265
Dis Colon Rectum. 2023 Jan 1;66(1):10-13
pubmed: 36515511
Dis Colon Rectum. 2007 Sep;50(9):1297-305
pubmed: 17665254
Dis Colon Rectum. 2007 Jun;50(6):878-92
pubmed: 17380367
Front Neurol. 2022 Jun 03;13:811298
pubmed: 35720077
J Gastrointest Surg. 2020 Feb;24(2):405-410
pubmed: 30783957
Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):513-21
pubmed: 23752820
Dis Colon Rectum. 2018 Mar;61(3):284-292
pubmed: 29420423
Colorectal Dis. 2009 Mar;11(3):282-7
pubmed: 18513198
Pain Ther. 2021 Jun;10(1):675-689
pubmed: 33840060
Dis Colon Rectum. 1990 Sep;33(9):770-2
pubmed: 2390913
J Invest Surg. 2018 Oct;31(5):420-424
pubmed: 29172862
Tech Coloproctol. 2004 Mar;8(1):11-4
pubmed: 15057582

Auteurs

Qing Long (Q)

Department of Traditional Chinese Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

Jun Li (J)

Department of Traditional Chinese Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

Yan Li (Y)

Department of Dermatology, Traditional Chinese Medicine Hospital Affiliated to Southwest Medical University, Luzhou, China.

Classifications MeSH